|
Thrombin Generation Inhibitors |
|
|---|---|
|
Short Description |
Methods and medicines for inhibiting blood coagulations. |
|
Abstract |
Existing blood anticoagulants produce a number of deleterious side effects. For example, heparin, warfarins, and thrombolytic agents all can cause bleeding. The present invention has discovered that certain peptides derived from the region comprising amino acids 307 to 356 of the human blood coagulation factor Va exhibit excellent blood coagulation properties with little or no adverse side effects. |
|
Inventor(s) |
Dr. Michael Kalafatis, Ph.D. Professor, Department of Chemistry. |
|
Commercial Applications |
|
|
Advantages |
|
|
IP Information |
|
|
Related IP |
|
|
Status |
Available |